** Shares of Trajan Group Holdings rise as much as 5% to A$1.260, posting their biggest intraday pct gain since Sept. 10
** Life sciences co says Q1 total net revenue up in high single-digit over pcp
** Maintains FY25 net revenue forecast of A$160.0 mln ($105.31 mln) to A$165.0 mln, and group nEBITDA of A$17.0 mln to A$19.0 mln
** Co had reported net revenue of A$155 mln and group normalised EBITDA of A$17.1 mln for fiscal 2024
** Stock hits highest level since Oct. 7
** TRJ up 2% YTD, as of 0225 GMT
($1 = 1.5193 Australian dollars)
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.